- Category
- Small (2023-24)
- Udyam number
- UDYAM-UP-42-0003760

About Penta Pharma Private Limited
Data last updated:
Penta Pharma Private Limited is a private limited company based in Kanpur Dehat, Uttar Pradesh, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 17 October 1991 and has been in existence for over 35 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24231UP1991PTC013617. Its GSTIN is 09AACCP5409R1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.99 Cr. It is led by directors including Rajeev Kumar Maheshwari (Managing Director) and Shikhar Maheshwari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 79 Goverment Industrial Estate Rania, Kanpur Dehat, Uttar Pradesh, India – 209304.
As per the financials filed for FY 2023, the company reported a revenue of ₹10.84 Cr. For the same year it recorded a net profit of ₹12.95 Lakh (net margin 1.2%) and EBITDA of -₹5.42 Cr (EBITDA margin -50%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 51% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Pentapharm. As per MCA filings, the company has open charges of ₹20.94 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 2 cases are pending.
Penta Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-42-0003760). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pentapharma.netlify.app.
Recognitions & Rankings of Penta Pharma
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address79 Goverment Industrial Estate Rania, Kanpur Dehat, Uttar Pradesh, India – 209304
- IndustryAgriculture, Crop Protection, Fertilizers & Soil Enhancers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Penta Pharma Private Limited
Penta Pharma operates one associated brand: PENTAPHARM. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Supplies active ingredients, reagents, and enzymes for diagnostics and pharmaceuticals sectors. | pentapharm.com |
Financials of Penta Pharma Private Limited FY 2024 filings available
Penta Pharma Private Limited reported revenue of ₹10.84 Cr for FY 2023.
Compounded Annual Growth Rate (CAGR) of Penta Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 51% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Penta Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹10.84 Cr | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹5.42 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.95 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Penta Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -50% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Penta Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Penta Pharma Private Limited
Penta Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shikhar Maheshwari | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
| Rajeev Kumar Maheshwari | Managing Director | 17 Oct 1991 | 35 Years 0 Months | Current |
| Padma Maheshwari | Director | 20 Feb 2018 | 8 Years 8 Months | Current |
Auditor Details of Penta Pharma Private Limited
Penta Pharma Private Limited is audited by MITTAL NIRBHAY & COMPANY for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MITTAL NIRBHAY & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Penta Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Penta Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jul 2025 | Hdfc Bank Limited | ₹5.99 Cr | Open |
| 25 Jan 2024 | Others | ₹5.98 Cr | Open |
| 12 Mar 2022 | Bank of India | ₹10 Lakh | Open |
| 12 Mar 2022 | Bank of India | ₹10 Lakh | Open |
| 05 Oct 2019 | Bank of India | ₹10 Lakh | Open |
Total charge records: 9 View all charges
Legal Cases of Penta Pharma Private Limited
Penta Pharma Private Limited has 3 court cases on record: 1 filed by Penta Pharma, 2 filed against it. 2 cases are pending and 1 is disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 2 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kanpur Nagar, Uttar Pradesh | Criminal case | Filed by the company against Kalpesh Bhai Daya Bhai Patel Propertier Pratham Enterprises | Pending |
| District court, Kanpur Dehat, Uttar Pradesh | Civil suit | Filed against the company by Vings Grow LLP | Pending |
| District court, Kanpur Dehat, Uttar Pradesh | Interim or miscellaneous application | Filed against the company by Wings Pro. LLP | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Penta Pharma Private Limited
Penta Pharma Private Limited has a workforce of 38 employees as of Mar 29, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Penta Pharma Private Limited
Penta Pharma Private Limited has 4 board changes on record since 1991: 3 appointments and 1 cessation. The latest: Padma Maheshwari was appointed as Director on 20 Feb 2018.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Penta Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Penta Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Penta Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Penta Pharma Private Limited
Penta Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCP5409R1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Penta Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Penta Pharma Private Limited
Penta Pharma is an active private limited company based in Kanpur Dehat, Uttar Pradesh, India. The company works in crop protection, within the agriculture industry. It was incorporated on 17 October 1991 (35+ years old) and is registered under CIN U24231UP1991PTC013617.
Penta Pharma reported revenue of ₹10.84 Cr for FY 2023.
Penta Pharma has 3 current directors:
- Rajeev Kumar Maheshwari - Managing Director
- Shikhar Maheshwari - Director
- Padma Maheshwari - Director
Penta Pharma reported a net profit of ₹12.95 Lakh (net margin 1.2%) and EBITDA of -₹5.42 Cr (EBITDA margin -50%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Penta Pharma is -1% over three years and 51% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Penta Pharma is 09AACCP5409R1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Penta Pharma is U24231UP1991PTC013617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Penta Pharma has 3 court cases on record: 1 filed by the company and 2 filed against it. 2 are pending.
Penta Pharma was incorporated on 17 October 1991, making it 35+ years old. It is registered with the Registrar of Companies, Kanpur.
Padma Maheshwari was appointed as Director on 20 Feb 2018. Shikhar Maheshwari was appointed as Director on 20 Feb 2018. Suresh Kumar Sharda ceased to be Director on 20 Feb 2018. Penta Pharma has 4 board changes on record in total.